[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT07591701":3,"trial-entities:NCT07591701":79,"trial-summary:NCT07591701":83},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":6,"overall_status":7,"completion_date":8,"status_verified_date":9,"last_update_date":10,"start_date":11,"sponsor_name":12,"lead_sponsor_class":13,"has_dmc":14,"brief_summary":15,"detailed_description":16,"conditions":17,"keywords":19,"study_type":20,"primary_purpose":21,"phases":22,"enrollment_info":24,"interventions":27,"primary_outcomes":34,"secondary_outcomes":39,"sex":40,"minimum_age":41,"maximum_age":42,"healthy_volunteers":43,"eligibility_criteria":44,"std_ages":48,"locations":51,"central_contacts":69,"overall_officials":72,"references":74,"see_also_links":75},"NCT07591701","2025-1431","Efforts to Increase Representation in Prostate Cancer Clinical Trials at Lyndon B. Johnson Hospital","RECRUITING","2030-01-31","2026-06","2026-06-26","2026-05-26","M.D. Anderson Cancer Center","OTHER",true,"The main rationale underlying this study is that prostate cancer clinical trials are lacking representation from racial and ethnic minority groups. Study proposal aims to target barriers at the participant, investigator, and health system level through specific interventions to increase the percentage of participants from these backgrounds on cancer clinical trials.","Primary Objectives:\n\nThe study objective is to increase the number of participants on prostate cancer clinical trials at LBJ. Investigators will complete several objectives:\n\n* To design a culturally tailored video highlighting participant narratives and determine its impact on participants' decision-making pertaining to joining a clinical trial\n* To conduct educational sessions with frontline oncology providers\n* To coordinate participant care through utilization of a nurse navigator\n* To evaluate the effectiveness of this multi-pronged intervention to increase enrollment onto two prostate cancer clinical trials and compare enrollment and one-year retention rates before and after the intervention",[18],"Prostate Cancer",[],"INTERVENTIONAL","HEALTH_SERVICES_RESEARCH",[23],"NA",{"count":25,"type":26},60,"ESTIMATED",[28],{"type":13,"name":29,"description":30,"armGroupLabels":31},"Video","Participants will watch a short video in clinic. Participants will complete the two validated scales before and after viewing the video.",[32,33],"To Conduct Educational Sessions with Frontline Oncology Providers","Video Intervention to Prostate Cancer Patient",[35],{"measure":36,"description":37,"timeFrame":38},"Safety and Adverse Events (AEs)","Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0","Through study completion; an average of 1 year",[],"MALE","18 Years",null,false,{"inclusion":45,"exclusion":46,"raw_text":47},[],[],"Inclusion Criteria:\n\nThese criteria include diagnosed prostate cancer patients receiving care at LBJ Hospital who\n\nAre eligible for an open prostate cancer clinical trial at LBJ Hospital during the study period\n\nCan provide informed consent.\n\nExclusion Criteria:\n\nThese criteria include prostate cancer patients receiving care at LBJ who are unable to participate due to a serious psychological or cognitive condition or have a medical condition that prevents participation in the trial.",[49,50],"ADULT","OLDER_ADULT",[52],{"facility":53,"status":7,"city":54,"state":55,"zip":56,"country":57,"contacts":58,"geoPoint":66},"The University of Texas M. D. Anderson Cancer Center","Houston","Texas","77090","United States",[59,64],{"name":60,"role":61,"phone":62,"email":63},"Debanjan Pain, MD","CONTACT","713-745-0075","dpain@mdanderson.org",{"name":60,"role":65},"PRINCIPAL_INVESTIGATOR",{"lat":67,"lon":68},29.76328,-95.36327,[70],{"name":60,"role":61,"phone":71,"email":63},"(713) 745-0075",[73],{"name":60,"affiliation":12,"role":65},[],[76],{"label":77,"url":78},"MD Anderson Cancer Center Website","http:\u002F\u002Fwww.mdanderson.org",{"nct_id":4,"conditions":80,"biomarkers":82},[81],"Prostate Carcinoma",[],{"nct_id":4,"found":14,"summary":84,"prompt_version":94},{"design":85,"status":86,"heading":87,"summary":88,"follow_up":89,"word_count":90,"commitments":91,"compensation":92,"drugs_mentioned":93},"This is an interventional study planning to enroll 60 participants. It will test the impact of a culturally tailored video and other interventions on clinical trial participation.","completed","Efforts to Increase Representation in Prostate Cancer Clinical Trials","This study at Lyndon B. Johnson Hospital aims to increase the number of men from diverse racial and ethnic backgrounds who join prostate cancer clinical trials. Researchers will use a short video in the clinic, along with educational sessions for healthcare providers and support from a nurse navigator, to help more patients participate. You might be able to join if you are an adult man with prostate cancer receiving care at LBJ Hospital, are eligible for another open prostate cancer clinical trial there, and can give informed consent. The main goal is to see if these efforts improve enrollment and how well participants stay in trials for one year. The current status of this study is unclear.","Participants will be followed for safety and adverse events through study completion, which is an average of one year.",117,"Participants will watch a short video in the clinic and complete two questionnaires before and after viewing it. The study will track safety and adverse events for about one year.","Not stated in the trial record.",[29],"v2"]